Cost of Precision Medicine at a Referral Center for Cystic Fibrosis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
de Azevedo L, Cruz F, Martins J, Marson F Diagnostics (Basel). 2023; 13(4).
PMID: 36832251 PMC: 9954801. DOI: 10.3390/diagnostics13040763.
McGarry M, Gibb E, Oates G, Schechter M Paediatr Respir Rev. 2022; 42:35-42.
PMID: 35277357 PMC: 9356388. DOI: 10.1016/j.prrv.2021.12.001.
References
1.
Kmit A, Marson F, Pereira S, Vinagre A, Leite G, Servidoni M
. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1323-1331.
DOI: 10.1016/j.bbadis.2019.01.029.
View
2.
Keating D, Marigowda G, Burr L, Daines C, Mall M, McKone E
. VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018; 379(17):1612-1620.
PMC: 6289290.
DOI: 10.1056/NEJMoa1807120.
View
3.
Pereira S, Ribeiro J, Ribeiro A, Bertuzzo C, Marson F
. Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools. Sci Rep. 2019; 9(1):6234.
PMC: 6470152.
DOI: 10.1038/s41598-019-42404-6.
View
4.
Taylor-Cousar J, Munck A, McKone E, van der Ent C, Moeller A, Simard C
. Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. N Engl J Med. 2017; 377(21):2013-2023.
DOI: 10.1056/NEJMoa1709846.
View
5.
Davies J, Moskowitz S, Brown C, Horsley A, Mall M, McKone E
. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018; 379(17):1599-1611.
PMC: 6277022.
DOI: 10.1056/NEJMoa1807119.
View